Roche’s Genentech unit will cut 3% of workers, a spokesperson told Endpoints News Wednesday, making it the latest drugmaker to announce staffing reductions in recent weeks.
“We regularly evaluate our operations to ensure we remain well-positioned to meet the needs of patients today while continuing to deliver innovative new medicines in the future,” the spokesperson said in an email. The move impacts “several departments,” the spokesperson said.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.